skip to Main Content

DOWNLOAD THE PAYER DOSSIER

Add TBS Osteo to your DXA routine to benefit from the NEW US Reimbursement codes. Plus, with TBS Osteo being seamlessly integrated to your DXA workflow, you can increase the value of your existing DXA practice and provide better patient care.

Download the payer dossier and see:

  • Demonstration of the Clinical Need for TBS in assessment of fracture risk
  • Evidence of Clinical Utility
  • A subset of Clinical Evidence to support payer coverage
  • National and International Medical Organizations with Guidelines supporting use of TBS

THE MISSING LINK TO FRACTURE PREDICTION

FACTS

30% of osteopenic patients are about the same risk of fracture as some of those who are osteoporotic, but aren’t classified or managed accordingly1

Evidence suggests that many women who sustain a fragility fracture are not appropriately diagnosed and treated for probable osteoporosis2,3,4,5

The great majority of individuals at high risk (possibly 80%), who have already had at least one osteoporosis fracture, are neither identified nor treated6

BMD alone does not satisfy the WHO definition of osteoporosis, which is described as ‘a silent systemic skeletal disease characterized by low bone mass (BMD) and a micro-architectural deterioration (TBS) of bone tissues leading to an important increase of bone fragility and increase fracture risk.’

Standard DXA procedures only provide information for half of the definition – only BMD, not structure.

BMD alone cannot identify all patients who are at risk of fracture

Over 50% of patients with osteoporotic fractures have normal or osteopenic BMD values. These patients are underdiagnosed with BMD alone1

Two patients can have the same BMD but that doesn’t mean they are at the same risk of fracture

WHY?

TBS OSTEO IS A CLINICAL ADDED VALUE FULFILLING THE WHO OSTEOPOROSIS DEFINITION

+0
publications supporting a highly clinically validated and clinically accepted product
+0
years of combined extensive leadership experience in bone health and imaging
+0
national and international guidelines recommend TBS – recognized as new standard
+0
countries in which TBS is commercially present

WHAT IS TBS OSTEO?

TBS Osteo is an advanced imaging software application for bone densitometers (DXA) assessing the microarchitectural deterioration of bone tissue. It computes a Trabecular Bone Score (TBS), which provides extremely useful additional clinical information as to the microarchitecture of the bone.
The combination of TBS, BMD and clinical risk factors or FRAX provides a more comprehensive overview of a patient’s bone health.
DXA + TBS = Density + Structure

3 EASY STEPS

1. DXA SCAN

2. TBS AUTOMATIC DETECTION

3. TBS ALL-IN-ONE REPORT

BENEFITS OF TBS OSTEO

Discover the clinical, financial, and operational benefits of TBS Osteo

NEW US REIMBURSEMENT CODES

Trabecular bone score (TBS) has four new dedicated CPT codes for reimbursement beginning January 2022

EASY TO USE

  • Easy to install and use
  • Easy to interpret by practitioners

MORE REVENUE

  • Identify more patients at risk of fracture
  • More returning patients
  • More referrals and improved reputation

IMPROVED PATIENT MANAGEMENT

  • Fine-tune therapy decision (based on monitoring changes of TBS across time)
  • Fully all-in-one automated report (editable) combining all the findings 
  • Analyzes retrospectively patient database

SEAMLESSLY INTEGRATED TO YOUR CURRENT WORKFLOW

  • No additional radiation exposure nor scan time
  • Integrated into workflow for both patient and technician

UP YOUR DXA BUSINESS

Add TBS Osteo to your DXA routine to benefit from the NEW US Reimbursement codes.

1The Manitoba Study: Prospective study that aimed to elucidate the ability of lumbar spine TBS to predict future clinical osteoporotic fractures. Sample: 29,407 women age 50 or older at time of baseline in the Canadian province of Manitoba, mean follow-up time of 4.7 years. Hans et al. ,2011, J. Bone Miner. Res. 26
2Freedman, K.B., et al., Treatment of osteoporosis: are physicians missing an opportunity? J Bone Joint Surg Am, 2000. 82-A(8): p. 1063-70.
3Siris, E.S., et al., Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment
4International Osteoporosis Foundation: Broken bones, broken lives: a roadmap to solve the fragility fracture crisis in Europe. 2018
5Shah, A., et al., Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study. Osteoporos Int, 2017. 28(1): p. 169-178
6Hernlund, E., et al., Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos, 2013. 8: p. 136.

Back To Top